Skip to main content
TipRanks
Go Ultimate75% OFF

ARS Pharmaceuticals (SPRY) Q2 2021 Earnings Report

593 Followers

SPRY Q2 2021 EPS Results

Actual EPS
-$0.70
Consensus EPS
-$0.54
Beat/Miss
Missed by -$0.16
One Year Ago EPS
-$0.19

SPRY Q2 2021 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2021
Date
08/12/2021
Time
After Close
Conference Call
Thursday, August 12, 2021
SPRY Upcoming Earnings

ARS Pharmaceuticals's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

SPRY Earnings History

SPRY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)-0.28--0.41――
Nov 05, 20262026 (Q3)-0.30-0.36-0.5230.77% (+0.16)
Aug 13, 20262026 (Q2)-0.48-0.63-0.46-36.96% (-0.17)
May 15, 20262026 (Q1)-0.52-0.61-0.35-74.29% (-0.26)
Mar 09, 20262025 (Q4)-0.43-0.410.48-185.42% (-0.89)
Nov 10, 20252025 (Q3)-0.45-0.52-0.2-160.00% (-0.32)
Aug 13, 20252025 (Q2)-0.46-0.46-0.13-253.85% (-0.33)
May 14, 20252025 (Q1)-0.34-0.35-0.11-218.18% (-0.24)
Mar 20, 20252024 (Q4)-0.240.48-0.07785.71% (+0.55)
Nov 13, 20242024 (Q3)-0.14-0.20-0.16-25.00% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed